$210 Million is the total value of Alphabet Inc.'s 3 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q2 2016 |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPERO THERAPEUTICS INC | 27 | Q2 2024 | 3.5% |
AUTOLUS THERAPEUTICS PLC | 25 | Q2 2024 | 2.8% |
DEXCOM INC | 23 | Q2 2024 | 21.2% |
ALECTOR INC | 22 | Q2 2024 | 1.1% |
Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
QUINCE THERAPEUTICS INC | 21 | Q2 2024 | 0.6% |
Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
FULCRUM THERAPEUTICS INC | 20 | Q2 2024 | 0.7% |
RAPT THERAPEUTICS INC | 19 | Q2 2024 | 1.4% |
Lyft Inc | 18 | Q2 2023 | 51.9% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
144 | 2024-09-27 |
4 | 2024-09-27 |
4 | 2024-09-27 |
4 | 2024-09-27 |
4 | 2024-09-27 |
4 | 2024-09-26 |
4 | 2024-09-26 |
4 | 2024-09-26 |
4 | 2024-09-24 |
8-K | 2024-09-24 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.